© Provided by Xinhua BEIJING, Oct. 3 (Xinhua) Pinellia is a common type of traditional Chinese medicine (TCM) used in the country for centuries, yet
Intl forum seeks to promote greater understanding of TCM culture chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
SOURCE / ECONOMY
BRI countries and regions embracing Chinese medicine
By GT staff reporters Published: May 17, 2021 04:53 PM
Filled capsules awaiting aluminum plastic quality testing at a production line of Shijiazhuang Yiling Pharmaceutical. Photo: Courtesy of Shijiazhuang Yiling Pharmaceutical
The traditional Chinese medicine (TCM) has gained greater momentum on going global, boosted by its unprecedented role in the pandemic prevention and control, especially throughout countries along the Belt and Road, becoming an important containing tool to slow down the spreading of the deadly virus.
China s top leadership has all along called for bigger efforts to develop TCM so that more people in the world could benefit from it. The medicine has lately been increasingly embraced by more people from the world, thanks to its effect in combating the COVID-19, SARS and other infectious diseases.
Herbal solutions to the COVID-19 pandemic?
Published Tuesday 26 January 2021
These are the words of President Gurbanguly Berdymukhamedov of Turkmenistan. The plant he referred to is licorice. With is the promotion of a herbal solution for the pandemic, he is in good company:
The health authorities of Tamil Nadu distributed herbal medicine to the general public as a preventive measure against Coronavirus disease.
Madagascar claims to have a cure for Covid-19, the herbal tea named Covid-Organics has the plant artemisia as an ingredient.
China has been using TCM alongside conventional treatment methods to treat Covid-19 patients. Some of the herbal formulations used in the treatment are:
Yiling Pharma expects to double its YoY net profit in 2020
News provided by
Share this article
Share this article
SHIJIAZHUANG, China, Jan. 6, 2021 /PRNewswire/ Yiling Pharmaceutical, a Shenzhen stock market listed enterprise (002603.SZ), has recently published its 2020 earnings projection. The yearly net profit belonging to its shareholders is anticipated to be between 1.152 billion Chinese yuan and 1.274 billion Chinese yuan, yearly growth between 90% and 110%, basic earnings per share between 0.97 Chinese yuan and 1.07 Chinese yuan. 2020 witnessed a speeding-up growth.
The earnings projection listed two reasons for the growth: the visibility and influence of Lianhua Qingwen products has been significantly enhanced, which brought about strong demand for the products from foreign and domestic markets; the enterprise won the 1st Prize of the 2019 National Scientific & Technological Progress Awards, which promoted the sales of its cardio-cerebral-vascular products.